Cargando…

Corticosteroids and risk of gastrointestinal bleeding: a systematic review and meta-analysis

OBJECTIVE: To assess whether corticosteroids are associated with increased risk of gastrointestinal bleeding or perforation. DESIGN: Systematic review and meta-analysis of randomised, double-blind, controlled trials comparing a corticosteroid to placebo for any medical condition or in healthy partic...

Descripción completa

Detalles Bibliográficos
Autores principales: Narum, Sigrid, Westergren, Tone, Klemp, Marianne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4025450/
https://www.ncbi.nlm.nih.gov/pubmed/24833682
http://dx.doi.org/10.1136/bmjopen-2013-004587
_version_ 1782316761877577728
author Narum, Sigrid
Westergren, Tone
Klemp, Marianne
author_facet Narum, Sigrid
Westergren, Tone
Klemp, Marianne
author_sort Narum, Sigrid
collection PubMed
description OBJECTIVE: To assess whether corticosteroids are associated with increased risk of gastrointestinal bleeding or perforation. DESIGN: Systematic review and meta-analysis of randomised, double-blind, controlled trials comparing a corticosteroid to placebo for any medical condition or in healthy participants. Studies with steroids given either locally, as a single dose, or in crossover studies were excluded. DATA SOURCES: Literature search using MEDLINE, EMBASE and Cochrane Database of Systematic Reviews between 1983 and 22 May 2013. OUTCOME MEASURE: Outcome measures were the occurrence of gastrointestinal bleeding or perforation. Predefined subgroup analyses were carried out for disease severity, use of non-steroidal anti-inflammatory drugs (NSAIDs) or gastroprotective drugs, and history of peptic ulcer. RESULTS: 159 studies (N=33 253) were included. In total, 804 (2.4%) patients had a gastrointestinal bleeding or perforation (2.9% and 2.0% for corticosteroids and placebo). Corticosteroids increased the risk of gastrointestinal bleeding or perforation by 40% (OR 1.43, 95% CI 1.22 to 1.66). The risk was increased for hospitalised patients (OR 1.42, 95% CI 1.22 to 1.66). For patients in ambulatory care, the increased risk was not statistically significant (OR 1.63, 95% CI 0.42 to 6.34). Only 11 gastrointestinal bleeds or perforations occurred among 8651 patients in ambulatory care (0.13%). Increased risk was still present in subgroup analyses (studies with NSAID use excluded; OR 1.44, 95% CI 1.20 to 1.71, peptic ulcer as an exclusion criterion excluded; OR 1.47, 95% CI 1.21 to 1.78, and use of gastroprotective drugs excluded; OR 1.42, 95% CI 1.21 to 1.67). CONCLUSIONS: Corticosteroid use was associated with increased risk of gastrointestinal bleeding and perforation. The increased risk was statistically significant for hospitalised patients only. For patients in ambulatory care, the total occurrence of bleeding or perforation was very low, and the increased risk was not statistically significant.
format Online
Article
Text
id pubmed-4025450
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-40254502014-05-21 Corticosteroids and risk of gastrointestinal bleeding: a systematic review and meta-analysis Narum, Sigrid Westergren, Tone Klemp, Marianne BMJ Open Gastroenterology and Hepatology OBJECTIVE: To assess whether corticosteroids are associated with increased risk of gastrointestinal bleeding or perforation. DESIGN: Systematic review and meta-analysis of randomised, double-blind, controlled trials comparing a corticosteroid to placebo for any medical condition or in healthy participants. Studies with steroids given either locally, as a single dose, or in crossover studies were excluded. DATA SOURCES: Literature search using MEDLINE, EMBASE and Cochrane Database of Systematic Reviews between 1983 and 22 May 2013. OUTCOME MEASURE: Outcome measures were the occurrence of gastrointestinal bleeding or perforation. Predefined subgroup analyses were carried out for disease severity, use of non-steroidal anti-inflammatory drugs (NSAIDs) or gastroprotective drugs, and history of peptic ulcer. RESULTS: 159 studies (N=33 253) were included. In total, 804 (2.4%) patients had a gastrointestinal bleeding or perforation (2.9% and 2.0% for corticosteroids and placebo). Corticosteroids increased the risk of gastrointestinal bleeding or perforation by 40% (OR 1.43, 95% CI 1.22 to 1.66). The risk was increased for hospitalised patients (OR 1.42, 95% CI 1.22 to 1.66). For patients in ambulatory care, the increased risk was not statistically significant (OR 1.63, 95% CI 0.42 to 6.34). Only 11 gastrointestinal bleeds or perforations occurred among 8651 patients in ambulatory care (0.13%). Increased risk was still present in subgroup analyses (studies with NSAID use excluded; OR 1.44, 95% CI 1.20 to 1.71, peptic ulcer as an exclusion criterion excluded; OR 1.47, 95% CI 1.21 to 1.78, and use of gastroprotective drugs excluded; OR 1.42, 95% CI 1.21 to 1.67). CONCLUSIONS: Corticosteroid use was associated with increased risk of gastrointestinal bleeding and perforation. The increased risk was statistically significant for hospitalised patients only. For patients in ambulatory care, the total occurrence of bleeding or perforation was very low, and the increased risk was not statistically significant. BMJ Publishing Group 2014-05-15 /pmc/articles/PMC4025450/ /pubmed/24833682 http://dx.doi.org/10.1136/bmjopen-2013-004587 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/
spellingShingle Gastroenterology and Hepatology
Narum, Sigrid
Westergren, Tone
Klemp, Marianne
Corticosteroids and risk of gastrointestinal bleeding: a systematic review and meta-analysis
title Corticosteroids and risk of gastrointestinal bleeding: a systematic review and meta-analysis
title_full Corticosteroids and risk of gastrointestinal bleeding: a systematic review and meta-analysis
title_fullStr Corticosteroids and risk of gastrointestinal bleeding: a systematic review and meta-analysis
title_full_unstemmed Corticosteroids and risk of gastrointestinal bleeding: a systematic review and meta-analysis
title_short Corticosteroids and risk of gastrointestinal bleeding: a systematic review and meta-analysis
title_sort corticosteroids and risk of gastrointestinal bleeding: a systematic review and meta-analysis
topic Gastroenterology and Hepatology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4025450/
https://www.ncbi.nlm.nih.gov/pubmed/24833682
http://dx.doi.org/10.1136/bmjopen-2013-004587
work_keys_str_mv AT narumsigrid corticosteroidsandriskofgastrointestinalbleedingasystematicreviewandmetaanalysis
AT westergrentone corticosteroidsandriskofgastrointestinalbleedingasystematicreviewandmetaanalysis
AT klempmarianne corticosteroidsandriskofgastrointestinalbleedingasystematicreviewandmetaanalysis